In the world of precision medicine, most startups are taking the traditional route of genetic testing. But Parallel Health, an emerging biotech powerhouse, is betting on a different microscopic ...
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results